In partnership with the Organization of African First Ladies against HIV/AIDS (OAFLA), the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) developed a tool kit on pediatric HIV treatment to guide African First Ladies in their advocacy efforts in country and within the region. With this toolkit, the First Ladies Offices have statistics, messages and key actions that they can undertake to advocate on pediatric HIV treatment. The tool kit touches on key areas important to addressing pediatric HIV treatment, including: PMTCT, early infant diagnosis (EID) and linkage to care, pediatric formulations, and stigma and discrimination. This toolkit will facilitate the achievement of the goals that OAFLA has developed in its strategic plan of 2014-2018. The Pediatric HIV Tool Kit was presented by EGPAF during a capacity building workshop for Technical Advisers to the First Ladies in Addis Ababa, Ethiopia on January 27, 2016.
Explore Related Resources
Issue Briefs
Common Ground for Global Health Policy Brief: Pediatric HIV
Published June 2026
Overview Children* are disproportionately affected by the HIV epidemic yet are consistently deprioritized and underserved compared to other affected populations. UNAIDS’ global treatment targets call for 95% of people living with HIV to know their status; 95% of people who know their status to be on treatment; and 95% of people on treatment to sustain […]
View Resource
Topics:
Advocacy,
Pediatric HIV
Countries:
Global
sample caption 4
Fact Sheets
The Pediatric Treatment Gap
Published March 2026
View ResourceTopics:
HIV,
Pediatric HIV
Countries:
Global
Issue Briefs
Accelerating Progress to Ending Pediatric HIV
Published March 2026
We are at a critical inflection point for children affected by HIV. In 2024 alone, 120,000 children were newly infected, and, without timely treatment, half of HIV positive infants will not reach their second birthday. Children remain left behind—a child with HIV is 6 times more likely to die than an adult without timely diagnosis. […]
View Resource
Topics:
HIV,
Pediatric HIV
Countries:
Global